To facilitate the proposed use of graphene and its derivative graphene oxide (GO) in
widespread applications, we explored strategies that improve the biocompatibility of graphene …

… Author links open overlay panel David Urick a , Brandon Sciavolino b , Timothy Y. Wang
c , Dhanesh K. Gupta d , Alok Sharan e , Muhammed M. Abd-El-Barr c … Weng, D. Ma …

… d and K D ). Commercially available NLRP3 was bound to the biosensor tip, then various
concentrations (55 μM, 18 μM, 6 μM, 1.8 μM, 180 nM, 18 nM and 1.8 nM) of full-length vimentin …

Currently, axillary lymph node dissection is increasingly being replaced by the sentinel node
procedure. This method is time-consuming and the full immunohistochemical evaluation is …

… After 24 h, PM 2.5 - and asbestos-treated mice demonstrated increased protein (Figure 2C)
and cell count (Figure 2D) in bronchoalveolar lavage fluid and influx of neutrophils into the …

Background Prion disease is neurodegenerative disease that is typically fatal within months
of first symptoms. Clinical trials in this rapidly declining symptomatic patient population have …

… Hagar of the US Forest Service, Patrick D. Karns of the Minnesota Department of Natural
Resources, and L. David … D. Deciduous and coniferous heights 8.1 24.2 41.5 30.5 over 15 m tall …

… Signals transduced by FGF23 via the Klotho–FGFR complex inhibit 1,25-(OH) 2 vitamin
D 3 and parathyroid hormone synthesis and promote renal phosphate excretion. kl/kl mice …

… (D) We also measured the apparent permeability co-efficient (Papp) of fluorescein sulfonic
acid (FSA) in the apical to basolateral direction across the Caco-2 cells. (E) Percent change in …

… (D) We treated MH-S cells with PM or control and with forskolin (50 μM) or control and
measured cAMP levels 1 minute after forskolin treatment. (E) We treated MH-S cells with antimycin …